NuCana (NCNA) shares dropped about 70% in recent trading on Tuesday after the company priced a direct offering of around 10.85 American depositary shares to raise about $7 million.
Each ADS will be accompanied by a series A warrant to buy one ADS at an initial exercise price of $0.8068 per share and a series B warrant to buy one ADS at $1.61 per share, the company said.
The combined offering price of each ADS with the accompanying warrants is $0.6454, it said, adding that pre-funded warrants may be purchased in lieu of the ADSs.
The offering is expected to close Wednesday, NuCana said.
The company said it plans to use the proceeds to fund activities relating to its drug discovery and development programs, and for other general corporate purposes.
Price: 0.34, Change: -0.76, Percent Change: -68.82
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。